DK0929567T3 - Forbedret fastfase-peptidsyntese og middel til anvendelse af en sådan syntese - Google Patents

Forbedret fastfase-peptidsyntese og middel til anvendelse af en sådan syntese

Info

Publication number
DK0929567T3
DK0929567T3 DK97939974T DK97939974T DK0929567T3 DK 0929567 T3 DK0929567 T3 DK 0929567T3 DK 97939974 T DK97939974 T DK 97939974T DK 97939974 T DK97939974 T DK 97939974T DK 0929567 T3 DK0929567 T3 DK 0929567T3
Authority
DK
Denmark
Prior art keywords
synthesis
phase peptide
solid phase
enhanced solid
peptide synthesis
Prior art date
Application number
DK97939974T
Other languages
Danish (da)
English (en)
Inventor
Arne Holm
Bjarne Due Larsen
Original Assignee
Zealand Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma As filed Critical Zealand Pharma As
Application granted granted Critical
Publication of DK0929567T3 publication Critical patent/DK0929567T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
DK97939974T 1996-09-09 1997-09-09 Forbedret fastfase-peptidsyntese og middel til anvendelse af en sådan syntese DK0929567T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK97196 1996-09-09
EP97939974A EP0929567B1 (en) 1996-09-09 1997-09-09 Solid-phase peptide synthesis
PCT/DK1997/000375 WO1998011125A1 (en) 1996-09-09 1997-09-09 Improved solid-phase peptide synthesis and agent for use in such synthesis

Publications (1)

Publication Number Publication Date
DK0929567T3 true DK0929567T3 (da) 2005-06-27

Family

ID=8099561

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97939974T DK0929567T3 (da) 1996-09-09 1997-09-09 Forbedret fastfase-peptidsyntese og middel til anvendelse af en sådan syntese

Country Status (14)

Country Link
US (1) US7348404B2 (cs)
EP (1) EP0929567B1 (cs)
JP (1) JP4405594B2 (cs)
AT (1) ATE290014T1 (cs)
AU (1) AU723268B2 (cs)
CA (1) CA2265900C (cs)
CZ (1) CZ295838B6 (cs)
DE (1) DE69732640T2 (cs)
DK (1) DK0929567T3 (cs)
ES (1) ES2239364T3 (cs)
HU (1) HU230354B1 (cs)
IL (1) IL128829A (cs)
PT (1) PT929567E (cs)
WO (1) WO1998011125A1 (cs)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1950223A3 (en) * 1998-03-09 2009-05-13 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US6528486B1 (en) 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
US7550425B2 (en) 2000-06-16 2009-06-23 Zealand Pharma A/S Diuretic peptide conjugates
JP4903709B2 (ja) 2004-10-19 2012-03-28 ロンザ アーゲー 固相ペプチド合成のための方法
ES2361095T5 (es) 2005-05-04 2021-11-23 Zealand Pharma As Análogos del péptido 2 tipo glucagón (GLP-2)
GB0514071D0 (en) 2005-07-07 2005-08-17 Zealand Pharma As N- or C- terminally modified small peptides
US20090171097A1 (en) * 2005-11-22 2009-07-02 Hiroshi Sugiyama Automated solid phase synthesis of pyrrole-imidazole polyamide
JP5473334B2 (ja) 2005-12-23 2014-04-16 ジーランド ファーマ アクティーゼルスカブ 修飾リジン模倣化合物
JP5295785B2 (ja) * 2006-02-20 2013-09-18 エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション 細胞膜透過性ペプチド
CA2647867C (en) * 2006-03-29 2015-11-03 Otsuka Chemical Co., Ltd. Method for production of peptide thioester compound
WO2008056155A1 (en) 2006-11-08 2008-05-15 Zealand Pharma A/S Selective glucagon-like-peptide-2 (glp-2) analogues
DK2158214T3 (da) 2007-06-15 2011-12-05 Zealand Pharma As Glukagonanaloger
EA020537B1 (ru) 2008-12-15 2014-11-28 Зилэнд Фарма А/С Аналоги глюкагона
US8642540B2 (en) 2008-12-15 2014-02-04 Zealand Pharma A/S Glucagon analogues
CN102282166B (zh) 2008-12-15 2015-04-01 西兰制药公司 胰高血糖素类似物
ES2502218T3 (es) 2008-12-15 2014-10-03 Zealand Pharma A/S Análogos de glucagón
EA022816B1 (ru) 2009-07-13 2016-03-31 Зилэнд Фарма А/С Ацилированные аналоги глюкагона
EA023925B1 (ru) 2010-04-27 2016-07-29 Зилэнд Фарма А/С Пептидные конъюгаты агонистов рецептора glp-1 и их применение
AR081975A1 (es) 2010-06-23 2012-10-31 Zealand Pharma As Analogos de glucagon
WO2011160633A1 (en) 2010-06-24 2011-12-29 Zealand Pharma A/S Glucagon analogues
PH12013501495A1 (en) 2011-01-20 2013-09-16 Zealand Pharma As Combination of acylated glucagon analogues with insulin analogues
WO2013064669A1 (en) 2011-11-03 2013-05-10 Zealand Pharma A/S Glp-1 receptor agonist peptide gastrin conjugates
AP2014007797A0 (en) 2011-12-23 2014-07-31 Boehringer Ingelheim Int Glucagon analogues
WO2013098408A1 (en) 2011-12-30 2013-07-04 Zealand Pharma A/S Glucagon and cck receptor agonist peptide conjugates
US9657062B2 (en) 2012-02-03 2017-05-23 Zealand Pharma A/S Ghrelin analogues
CA2872315A1 (en) 2012-05-03 2013-11-07 Zealand Pharma A/S Glucagon-like-peptide-2 (glp-2) analogues
EA028665B1 (ru) 2012-05-03 2017-12-29 Зилэнд Фарма А/С Соединения - двойные агонисты gip-glp-1 и способы
EP2875043B1 (en) 2012-07-23 2016-12-21 Zealand Pharma A/S Glucagon analogues
TWI608013B (zh) 2012-09-17 2017-12-11 西蘭製藥公司 升糖素類似物
WO2014164680A1 (en) 2013-03-12 2014-10-09 Molecular Templates, Inc. Cd20-binding immunotoxins for inducing cellular internalization and methods using same
US9695214B2 (en) 2013-03-15 2017-07-04 Massachusetts Institute Of Technology Solid phase peptide synthesis processes and associated systems
US9169287B2 (en) 2013-03-15 2015-10-27 Massachusetts Institute Of Technology Solid phase peptide synthesis processes and associated systems
HK1219477A1 (zh) 2013-03-21 2017-04-07 Sanofi-Aventis Deutschland Gmbh 合成含有乙内酰脲的肽产物
EP2976325B1 (en) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthesis of cyclic imide containing peptide products
AU2014336098B2 (en) 2013-10-17 2018-05-10 Boehringer Ingelheim International Gmbh Acylated glucagon analogues
US9988429B2 (en) 2013-10-17 2018-06-05 Zealand Pharma A/S Glucagon analogues
WO2015067715A2 (en) 2013-11-06 2015-05-14 Zealand Pharma A/S Gip-glp-1 dual agonist compounds and methods
WO2015067716A1 (en) 2013-11-06 2015-05-14 Zealand Pharma A/S Glucagon-glp-1-gip triple agonist compounds
US10435474B2 (en) 2013-12-24 2019-10-08 Ossianix, Inc. Baff selective binding compounds and related methods
WO2015138452A1 (en) 2014-03-11 2015-09-17 Molecular Templates, Inc. Proteins comprising amino-terminal proximal shiga toxin a subunit effector regions and cell-targeting immunoglobulin-type binding regions
CA2937407A1 (en) 2014-01-27 2015-07-30 Molecular Templates, Inc. De-immunized shiga toxin a subunit effector polypeptides for applications in mammals
CA2940252C (en) 2014-03-11 2022-10-18 Molecular Templates, Inc. Proteins comprising binding regions, shiga toxin a subunit effector regions, and carboxy-terminal, endoplasmic reticulum localization signal motifs
EP3514168B1 (en) 2014-06-11 2021-09-01 Molecular Templates, Inc. Protease-cleavage resistant cytotoxic cell-targeting molecules
CA2953569A1 (en) 2014-06-26 2015-12-30 Ossianix, Inc. Semi-synthetic nurse shark vnar libraries for making and using selective binding compounds
EP3212218B1 (en) 2014-10-29 2021-06-30 Zealand Pharma A/S Gip agonist compounds and methods
WO2016077840A2 (en) 2014-11-14 2016-05-19 Ossianix, Inc. TfR SELECTIVE BINDING COMPOUNDS AND RELATED METHODS
ES2856457T3 (es) 2015-02-05 2021-09-27 Molecular Templates Inc Moléculas de unión a CD20 multivalentes que comprenden regiones efectoras de una subunidad de toxina shiga y composiciones enriquecidas de estas
EA035791B1 (ru) 2015-03-18 2020-08-11 Зилэнд Фарма А/С Аналоги амилина
GB201506380D0 (en) 2015-04-15 2015-05-27 Serodus Asa Materials and methods for treatment of pulmonary hypertension
US10336802B2 (en) 2015-04-16 2019-07-02 Zealand Pharma A/S Acylated glucagon analogue
DK3303373T3 (da) 2015-05-30 2020-06-02 Molecular Templates Inc Deimmuniserede Shiga toksin A-underenhedsstilladser og cellemålrettede molekyler omfattende samme
JP6884133B2 (ja) 2015-07-26 2021-06-09 モレキュラー テンプレーツ, インク.Molecular Templates, Inc. 志賀毒素ａサブユニットエフェクター及びｃｄ８＋ｔ細胞エピトープを含む細胞標的化分子
CA2999031A1 (en) 2015-09-17 2017-03-23 Massachusetts Institute Of Technology Methods and systems for solid phase peptide synthesis
US11097010B2 (en) 2016-08-06 2021-08-24 Ossianix, Inc. In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of use
US10071140B2 (en) 2016-09-09 2018-09-11 Zealand Pharma A/S Amylin analogues
CN110099922A (zh) 2016-12-09 2019-08-06 西兰制药公司 Glp-1/glp-2双重激动剂
WO2018104558A1 (en) 2016-12-09 2018-06-14 Zealand Pharma A/S Acylated glp-1/glp-2 dual agonists
WO2018104561A1 (en) 2016-12-09 2018-06-14 Zealand Pharma A/S Acylated glp-1/glp-2 dual agonists
WO2018104559A1 (en) 2016-12-09 2018-06-14 Zealand Pharma A/S Glp-1/glp-2 dual agonists
WO2018103868A1 (en) 2016-12-09 2018-06-14 Zealand Pharma A/S Acylated glp-1/glp-2 dual agonists
CA3049456A1 (en) 2017-01-25 2018-08-02 Molecular Templates, Inc. Cell-targeting molecules comprising de-immunized, shiga toxin a subunit effectors and cd8+ t-cell epitopes
PE20200678A1 (es) 2017-06-16 2020-06-11 Zealand Pharma As Posologias para la administracion de analogos de peptido de tipo glucagon-2 (glp-2)
US11512136B2 (en) 2017-11-02 2022-11-29 Ossianix, Inc. Transferrin receptor (TfR)-selective binding peptides capable of crossing the blood brain barrier and methods of use thereof
PE20201254A1 (es) 2018-02-27 2020-11-16 Zp Spv 3 K/S Analogos de compstatina y sus usos medicos
WO2019204272A1 (en) 2018-04-17 2019-10-24 Molecular Templates, Inc. Her2-targeting molecules comprising de-immunized, shiga toxin a subunit scaffolds
WO2019246288A1 (en) 2018-06-22 2019-12-26 Ossianix, Inc. Anti-cd98hc vnars for crossing the blood brain barrier and type iv vnar libraries
KR20210052389A (ko) 2018-08-27 2021-05-10 리제너론 파마슈티칼스 인코포레이티드 다운스트림 정제에서의 라만 분광법의 사용
WO2020056327A1 (en) 2018-09-14 2020-03-19 Ossianix, Inc. Tfr-specific binding moieties and transcytosis method to select vnars that cross cellular barriers
WO2020081493A1 (en) 2018-10-16 2020-04-23 Molecular Templates, Inc. Pd-l1 binding proteins
WO2020154531A1 (en) 2019-01-23 2020-07-30 Millennium Pharmaceuticals, Inc. Cd38-binding proteins comprising de-immunized shiga toxin a subunit effectors
US11414496B2 (en) 2019-01-23 2022-08-16 Takeda Pharmaceutical Company Limited Anti-CD38 binding domains
EP3982919A1 (en) 2019-06-14 2022-04-20 Zealand Pharma A/S Pharmaceutical parenteral composition of dual glp1/2 agonist
CA3148536A1 (en) 2019-08-27 2021-03-04 Anne Pernille Tofteng SHELTON Compstatin analogues and their medical uses
WO2021055816A1 (en) 2019-09-18 2021-03-25 Molecular Templates, Inc. Pd-l1 binding molecules comprising shiga toxin a subunit scaffolds
KR20220066095A (ko) 2019-09-20 2022-05-23 질랜드 파마 에이/에스 Kv1.3 차단제
WO2021102445A1 (en) 2019-11-24 2021-05-27 Molecular Templates, Inc. Uses of cd20-binding molecules and additional therapeutic agents
EP4126003A1 (en) 2020-03-30 2023-02-08 Zealand Pharma A/S Glp-1/glp-2 dual agonists
WO2021198195A1 (en) 2020-03-30 2021-10-07 Zealand Pharma A/S Agonist combination
CN116209671A (zh) 2020-07-16 2023-06-02 西兰制药第三特殊目的公司 补体因子c3的抑制剂及其医学用途
WO2022103769A1 (en) 2020-11-11 2022-05-19 Ossianix, Inc. High affinity human and monkey specific tfr-1 vnars
TW202241491A (zh) 2020-12-16 2022-11-01 丹麥商西蘭製藥公司 Ｇｌｐ－１／ｇｌｐ－２雙重促效劑之醫藥組合物
US20240299552A1 (en) 2020-12-16 2024-09-12 Zealand Pharma A/S Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists
JP2023553561A (ja) 2020-12-16 2023-12-22 ジーランド ファーマ エー／エス Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物
WO2022175410A1 (en) 2021-02-18 2022-08-25 Zealand Pharma A/S Composition for treating short bowel syndrome
US20220306700A1 (en) 2021-03-17 2022-09-29 Molecular Templates, Inc. Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens
BR112023019022A2 (pt) 2021-03-23 2023-10-17 Zealand Pharma As Bloqueadores de kv1.3
WO2022260877A1 (en) 2021-06-07 2022-12-15 Ossianix, Inc. Shark vnars for treating covid-19
KR20240022551A (ko) 2021-06-18 2024-02-20 베이징 투오 지에 바이오파마수티컬 컴퍼니 리미티드 글루카곤 유사체 및 이의 의학적 용도
WO2023023166A1 (en) 2021-08-17 2023-02-23 Ossianix, Inc. Deimmunized vnar domains and scaffolds
US20250073311A1 (en) 2021-09-03 2025-03-06 Zealand Pharma A/S Dosage regime
IL313185A (en) 2021-12-01 2024-07-01 Zealand Pharma As Peptide inhibitors of the interleukin-23 receptor
EP4593864A1 (en) 2022-09-28 2025-08-06 Zealand Pharma A/S Methods for treating obesity
KR20250089536A (ko) 2022-10-18 2025-06-18 질랜드 파마 에이/에스 억제제
WO2024168411A1 (pt) * 2023-02-15 2024-08-22 Proteimax Bio Technology Israel Ltd Aditivo de alimento e/ou suplemento alimentar, processo de obtenção, formulação de alimento funcional e/ou suplemento alimentar, uso
EP4471048A1 (en) 2023-06-01 2024-12-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
EP4471049A1 (en) 2023-06-01 2024-12-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
WO2025056677A1 (en) 2023-09-15 2025-03-20 Zealand Pharma A/S Dasiglucagon for use in the treatment of congenital hyperinsulinism
WO2025120002A1 (en) 2023-12-04 2025-06-12 Zealand Pharma A/S Petrelintide for reducing weight whilst preserving lean mass
WO2025120001A1 (en) 2023-12-04 2025-06-12 Zealand Pharma A/S Amylin analogues for reducing consumption of high-fat food

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116666A (cs) * 1974-07-30 1976-02-10 Shionogi Seiyaku Kk
US5021550A (en) * 1986-10-07 1991-06-04 Thomas Jefferson University Method for preventing deletion sequences in solid phase synthesis
JP2807287B2 (ja) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 ペプチドおよびその用途
JP3929484B2 (ja) * 1993-09-14 2007-06-13 ジェネンテック・インコーポレーテッド エコチンおよびその同族体を含む医薬的組成物
US7176282B1 (en) * 1996-09-09 2007-02-13 Zealand Pharma A/S Solid-phase peptide synthesis and agent for use in such synthesis
EP1950223A3 (en) * 1998-03-09 2009-05-13 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

Also Published As

Publication number Publication date
CA2265900C (en) 2007-07-31
DE69732640D1 (de) 2005-04-07
ATE290014T1 (de) 2005-03-15
HU230354B1 (hu) 2016-02-29
DE69732640T2 (de) 2006-01-12
AU4199397A (en) 1998-04-02
US20070004905A1 (en) 2007-01-04
AU723268B2 (en) 2000-08-24
JP2001500134A (ja) 2001-01-09
HUP0102900A2 (hu) 2002-01-28
CZ80399A3 (cs) 1999-08-11
WO1998011125A1 (en) 1998-03-19
IL128829A0 (en) 2000-01-31
PT929567E (pt) 2005-07-29
IL128829A (en) 2005-08-31
CZ295838B6 (cs) 2005-11-16
CA2265900A1 (en) 1998-03-19
EP0929567B1 (en) 2005-03-02
US7348404B2 (en) 2008-03-25
HUP0102900A3 (en) 2002-02-28
EP0929567A1 (en) 1999-07-21
JP4405594B2 (ja) 2010-01-27
ES2239364T3 (es) 2005-09-16

Similar Documents

Publication Publication Date Title
DK0929567T3 (da) Forbedret fastfase-peptidsyntese og middel til anvendelse af en sådan syntese
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
ATE271058T1 (de) Mycophenol bisphosponatverbindungen
ATE270303T1 (de) Gc1q-rezeptor, daran bindende hiv-1 gp120-region, verwandte peptide und antikörper
EA200300382A1 (ru) Способ поэтапного присоединения частей полиэтиленгликоля к полипептиду
DK1144607T5 (da) Fremgangsmåde til præsentation af (poly)peptider/proteiner på bakteriofage partikler via disulfidbindinger
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
BR9509665A (pt) Composto composições e métodos
FI961044A7 (fi) Kininogeeni-inhibiittorit
DK0855365T3 (da) Fremgangsmåde til fremstilling af syntesegas
DK1150999T3 (da) Cyclosporinderivater og fremgangsmåde til fremstilling deraf
ATE394482T1 (de) Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese
FI953525L (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
BR9707409A (pt) Sintese de análogo de vip
AU580350B2 (en) Process for synthesising peptides
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
ATE173022T1 (de) Produktion von peptid-amiden
DE69504795D1 (de) Methoden zur synthese und reinigung von peptiden
ATE385805T1 (de) Neue peptide
FI963854L (fi) Menetelmä kalsiumin talteenottamiseksi jäteaineksesta tai epäpuhtaasta luonnonkalsiumaineksesta
GR3015359T3 (en) Process for the production of peptides by solid phase synthesis.
GR3021660T3 (en) Anticoagulant peptides
NO960041D0 (no) Hemoregulatoriske penta- eller heksapeptider
NO984227L (no) Cycloalkylderivater og syntese i fast fase av slike derivater